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Abstract Elastic fibers in vessel walls and other tissues consist
of cross-linked tropoelastin in association with several micro-
fibrillar proteins. In order to understand the molecular basis of
these structures, we examined the binding of recombinant human
tropoelastin to other extracellular matrix ligands in solid phase
binding and surface plasmon resonance assays. These studies
demonstrated a particularly high affinity (Kd about 1 nM) of
tropoelastin for microfibrillar fibulin-2 and the recently described
nidogen-2 isoform. More moderate affinities were observed for
fibulin-1, laminin-1 and perlecan, while several other ligands such
as collagens, nidogen-1, fibronectin and BM-40 showed little or
no binding. In immunogold staining of mouse aortic media,
elastic fibers were heavily decorated with tropoelastin, fibulin-2
and nidogen-2, while the reaction with fibulin-1 was lower. The
colocalization of these proteins emphasizes the potential for in
vivo interactions.
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1. Introduction
Elastic ¢bers are characteristic extracellular structures
found in aorta and other vessel walls, lung, skin, elastic liga-
ments and cartilages, where they play a major role in allowing
the reversible deformation of tissues [1^3]. The core structure
of elastic ¢bers is composed of tropoelastin (72 kDa), which
forms a highly insoluble network through extensive cross-link-
ing mediated by lysyl oxidases. Four di¡erent models have
been proposed for the structure of these networks in order
to explain the mechanism of elasticity [1,2]. Due to its unique
sequence, tropoelastin is also known as the most hydrophobic
protein present in the extracellular matrix of vertebrates.
The supramolecular organization of elastic ¢bers also in-
cludes abundant 10^12 nm micro¢brils which are often depos-
ited at the periphery and considered to provide a sca¡old for
elastogenesis [1^3]. Major components of these micro¢brils
are the 350 kDa proteins ¢brillin-1 and ¢brillin-2 and natural
mutations of both ¢brillins are known to cause Marfan syn-
drome and related inherited disorders [4^6]. Further compo-
nents include the latent transforming growth factor-L binding
proteins (LTBPs), which are the closest structural relatives of
the ¢brillins [7]. As shown mainly by ultrastructural colocal-
ization studies, many more constituents are likely to be in-
volved in these micro¢brillar arrays. Potential candidates are
the 115 kDa emilin [8,9], the small micro¢bril-associated gly-
coproteins MAGP-1 and MAGP-2 [10,11], as well as several
other designated micro¢bril-associated proteins (MFAP) [12^
14], ¢bulin-1 [15] and ¢bulin-2 [16], lysyl oxidase [1,2], pro-
teoglycans [3,17] and the angiogenesis inhibitor endostatin
[17].
How these various constituents interact with one another at
the molecular level is much less clear and only a few in vitro
binding studies have been reported. They demonstrated bind-
ing of MAGP-1 to the C-terminal region of tropoelastin and
no binding of ¢brillin-1 [18,19]. Fibulin-2, however, shows a
distinct binding a⁄nity for an N-terminal segment of ¢brillin-
1 [16]. Likewise, endostatin may associate with the elastic
¢bers of vessel walls through binding to ¢bulin-2 and/or ni-
dogen-2 [17].
Recombinant tropoelastin and several deletion mutants
have now become available in su⁄ciently high quantities by
production in bacteria [20^24]. This tropoelastin was shown
to interact with cells [20,24] and lysyl oxidase [22] and to form
coacervates in a temperature-dependent fashion [24]. In the
present study, we have used recombinant tropoelastin in two
di¡erent binding assays in order to identify potential extra-
cellular matrix ligands. This demonstrated a particularly high
a⁄nity for ¢bulin-2 and nidogen-2 and more moderate inter-
actions with ¢bulin-1, laminin-1 and perlecan. Several of these
ligands could be localized by immunogold staining to the
aortic media. This indicates a high complexity in the supra-
molecular organization of elastic ¢bers not previously recog-
nized.
2. Materials and methods
2.1. Sources of proteins
Recombinant human tropoelastin which lacks the hydrophilic exon
26A was obtained by production in bacteria [20,22] and also used to
prepare an antiserum. Laminin-1 complexed to nidogen-1, collagen IV
and perlecan were puri¢ed from a mouse tumor basement membrane
[25]. Mouse nidogen-1 [26], ¢bulin-1C [27], ¢bulin-2 [28], endostatin
[29], human nidogen-2 [30] and BM-40 [31] were prepared in recombi-
nant form from the culture medium of transfected human cells. Pro-
teolytic fragments of laminin-1 [25] and recombinant fragments of
¢bulin-2 [32] and perlecan (see [33] for a summary) were obtained
as previously described. Bovine serum albumin (BSA) (Serva) and
human plasma ¢bronectin (Behringwerke) were commercial products.
2.2. Protein binding assays
Solid phase binding assays with one ligand immobilized onto the
plastic surface of microtiter wells followed previously used methods
[34]. Tropoelastin (2.67 mg/ml) was dissolved in 0.1% tri£uoroacetic
acid, 20% acetonitrile and stored at 370‡C. After dilution to 10 Wg/ml
in 0.05 M Tris-HCl, pH 7.4, 0.15 M NaCl (TBS), it was used imme-
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diately to coat the wells, followed by blocking with 1% BSA. Control
wells were coated and blocked with BSA alone in order to determine
non-speci¢c binding. Soluble ligands (0.01 to 1000 nM) were dissolved
in 1% BSA/TBS and their binding was detected by speci¢c antisera
[27,28,30].
Surface plasmon resonance assays were performed with BIAcore
1000 instrumentation (BIAcore AB). Tropoelastin was diluted to
200 Wg/ml in 0.1 M sodium acetate pH 4.0 and covalently coupled
[30] to CM-5 sensor chips (research grade) at 25‡C for 12 min (£ow
rate 5 Wl/min). Immobilization levels were adjusted to 3000^6000 res-
onance units (RU), which avoided mass transport problems and al-
lowed su⁄ciently high binding signals (30^450 RU) for a precise eval-
uation. Binding assays were performed with ligands (5^500 nM)
dissolved in TBS containing 0.05% P20 surfactant (BIAcore AB)
and 2 mM CaCl2 at 25‡C and a £ow rate of 20 Wl/min. Initial experi-
ments showed that this £ow rate was high enough to eliminate mass
transport problems. Associations were monitored for 3 min followed
by a dissociation phase of 30 min. Uncoated chips or chips coupled
with BSA were used to exclude non-speci¢c binding and bulk e¡ects.
Kinetic constants were calculated by non-linear ¢tting of the associ-
ation and dissociation curves according to a 1:1 model A+B = AB
following the manufacturer’s instructions (BIAevaluation software
version 3.0).
2.3. Immunogold staining
Immunoelectron microscopy followed recently applied procedures
[17,35]. Brie£y, pieces of aorta (about 1 mm2) from adult NMRI mice
were ¢xed in 4% paraformaldehyde and 0.5% glutaraldehyde and used
to obtain ultrathin sections. The labeling of 16 nm gold particles with
a⁄nity-puri¢ed goat anti-rabbit IgG (Medac) followed established
protocols. Tissue sections were incubated with the antiserum against
tropoelastin (1:300) or a⁄nity-puri¢ed rabbit antibodies against ¢bu-
lin-1 (6 Wg/ml), ¢bulin-2 (17 Wg/ml) or nidogen-2 (4 Wg/ml) and sub-
sequently with the gold-labeled antibodies (1:200). After staining with
uranyl acetate and lead citrate, sections were examined with a Zeiss
EM 109 electron microscope. Control sections that were incubated
with the gold-labeled antibodies showed no staining.
3. Results
Solid phase binding assays were used as an initial screen for
the binding of potential ligands to immobilized tropoelastin
(Table 1). A particularly strong interaction was observed with
¢bulin-2 and binding levels were about 10-fold lower with
nidogen-2 and the proteoglycan perlecan. The interactions
with ¢bulin-1C, laminin-1 and ¢bronectin were even weaker.
Several other extracellular ligands (collagens IV and VI, endo-
statin, BM-40) were inactive up to a concentration of 300^
1000 nM. This strongly indicated that tropoelastin discrimi-
nates between di¡erent protein ligands rather than binding
non-speci¢cally due to its hydrophobic character.
The interactions were dose dependent and several ligands
showed a clear plateau in their binding pro¢les when used at
Fig. 1. Binding of ¢bulins and nidogen-2 to plastic-immobilized tro-
poelastin. Assays were carried out in the presence of 2 mM CaCl2
(closed symbols) or 4 mM EDTA (open symbols). Soluble ligands
were ¢bulin-2 (b, a), nidogen-2 (F, E) and ¢bulin-1C (R, O).
Binding to serum albumin as a speci¢city control is only shown for
¢bulin-1C (7).
Fig. 2. Binding of recombinant fragments of ¢bulin-2 (A) and perle-
can (B) to plastic-immobilized tropoelastin. Soluble ligands in (A)
were ¢bulin-2 (b) and the ¢bulin-2 fragments N+I (F) and II+III
(R). Soluble ligands in (B) were perlecan (b) and the perlecan frag-
ments III-2 (S) and IA (R). Control binding to serum albumin is
shown by open symbols.
Table 1
Binding of soluble ligands to immobilized tropoelastin and serum
albumin in solid phase assays
Soluble ligand Tropoelastin Serum albumin
(OD) (nM) (OD) (nM)
Fibulin-1C 1.6 40 0.1 ^
Fibulin-2 1.6 6 0.05 0 ^
Nidogen-1 1.8 40 1.0 s 100
Nidogen-2 1.6 3 0.6 s 200
Perlecan 1.2 3 0.2 ^
Laminin-1 1.1 50 0.4 ^
Fibronectin 1.3 80 0 ^
Parameters of binding recorded are absorbance (OD) at 490 nm (ei-
ther in the plateau region or at 300 nM) and the concentration re-
quired for half maximal binding (nM). In the assays with ¢bulins
and nidogen-2 2 mM CaCl2 was added to the bu¡er. Laminin-1
was used as a complex with nidogen-1.
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high concentrations (Figs. 1 and 2). Furthermore, most of the
ligands showed no signi¢cant binding to serum albumin (Ta-
ble 1) which was used to block the wells coated with tropoe-
lastin. The exception was nidogen-1, leaving it open as to
whether the slight increase in binding to tropoelastin repre-
sents a speci¢c interaction. E⁄cient binding of ¢bulin-1C and
¢bulin-2 to tropoelastin was dependent on calcium (Fig. 1), as
shown previously for other ¢bulin ligands [27,28]. Addition of
EDTA caused a 25- to 50-fold reduction in binding activity.
This was, however, not the case for nidogen-2.
Surface plasmon resonance assays with immobilized tropo-
elastin were used to con¢rm and extend these binding data.
Most of the identi¢ed ligands showed a typical concentration-
dependent binding to tropoelastin, as illustrated for ¢bulin-2
in Fig. 3, which allowed association and dissociation rate
constants to be determined (Table 2). The strongest a⁄nity
was again observed for ¢bulin-2 (Kd = 0.6 nM), while 20- to
30-fold lower a⁄nities were found for ¢bulin-1C and laminin.
No binding was observed with soluble nidogen-2, which could
be due to destruction of binding epitopes on tropoelastin by
its covalent coupling to the sensor chip through lysine resi-
dues. Immobilization of nidogen-2 showed a clear binding of
soluble tropoelastin with Kd = 3 nM (Table 2), supporting this
interpretation. No binding to tropoelastin was observed for
nidogen-1, ¢bronectin and BM-40. Immobilized BSA was
used as a control and showed no binding of ¢bulin-1C, ¢bu-
lin-2, nidogen-2 and laminin-1.
Several tropoelastin ligands are also available in the form of
larger proteolytic or recombinant fragments. These were now
used for the mapping of binding epitopes. The N- and C-
terminal fragments N+I and II+III, respectively, which to-
gether correspond to the entire ¢bulin-2 molecule [32], both
showed only a weak binding to tropoelastin in solid phase
assays (Fig. 2A) and no interaction was detected by surface
plasmon resonance assay up to a concentration of 0.5 WM.
However, a clear binding was observed for fragments E3 and
E8 from the distal end of the long arm of laminin-1 [25], with
an a⁄nity comparable to that of the entire protein (Table 2).
Other fragments (E1X, E4) from laminin’s short arms showed
no signi¢cant binding. A complete set of perlecan fragments
[33] was also examined for tropoelastin binding by surface
plasmon resonance assays. Only a single fragment, III-2,
showed signi¢cant binding with Kd = 21 nM (Table 2). Since
perlecan could not be used as the soluble ligand in this assay,
a comparison was made in solid phase assays (Fig. 2B). This
demonstrated distinct binding of tropoelastin to perlecan, at
levels about 30-fold higher than to fragment III-2, and only
little binding to perlecan fragment IA which contains the hep-
aran sulfate chains.
Immunogold staining was used to examine whether elastic
lamellae in the media of mouse aorta contain the potential
ligands identi¢ed in the present study. Labeling was strong
and at comparable levels for tropoelastin and ¢bulin-2, with
moderate labeling for nidogen-2 and a low level for ¢bulin-1
(Fig. 4). Previous studies have shown a similar weak staining
for perlecan [17] and no reaction with a monoclonal antibody
against laminin-1 that reacts strongly with basement mem-
branes in other tissues [35]. Most of the staining was on ex-
tracellular amorphous and micro¢brillar regions. The anti-
bodies to ¢bulin-2 and nidogen-2 also showed a distinct
albeit less abundant intracellular localization, indicating either
active synthesis or resorption of these proteins.
4. Discussion
The strong in situ association of amorphous elastic ¢bers
with micro¢brillar components has been known for a long
time [1^3]. However, as yet only little information is available
about speci¢c molecular contacts from in vitro studies with
puri¢ed proteins. By using such assays, the present study pro-
vides evidence that recombinant tropoelastin binds to ¢bulin-
2, nidogen-2, perlecan, ¢bulin-1 and laminin-1. The a⁄nity of
binding decreased in the order of these ligands, as con¢rmed
by two di¡erent assays. As shown here and previously [15^17]
by ultrastructural analyses, all of these potential ligands ex-
Fig. 3. Concentration dependence of the binding of ¢bulin-2 to im-
mobilized tropoelastin in surface plasmon resonance assays. Soluble
ligands were injected at 120 s and replaced by bu¡er at 300 s. Up-
take and dissociation of protein is recorded in resonance units
(RU).
Table 2
Surface plasmon resonance assays of tropoelastin binding to extracellular matrix ligands
Immobilized ligands Soluble ligands kdU103 (s31) kaU1033 (M31 s31) Kd (nM)
Tropoelastin ¢bulin-1C 2.5 135 18 þ 9
¢bulin-2 1.5 2470 0.6 þ 0.2
nidogen-2 no binding
perlecan III-2 0.35 17 21
laminin-1 0.75 71 11 þ 4
laminin-1 E3 0.32 35 9 þ 4
laminin-1 E8 1.4 86 16 þ 5
Nidogen-2 tropoelastin 0.85 306 3 þ 2
Soluble ligands were used at various concentrations (5^500 nM) and showed an uptake in the range 30^450 RU. Kinetic and thermodynamic
constants are in most cases averages of 3^5 independent measurements with the error range ( þ S.D.) shown only for Kd values. Laminin-1 was
complexed to nidogen-1. E3, E8 and III-2 refer to fragments of these proteins.
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cept laminin-1 colocalize on elastic tissue ¢bers. This makes it
meaningful in a biological context to carry out a more precise
investigation of the supramolecular organization of such spe-
cialized extracellular structures.
Fibulin-2 was by far the strongest ligand for tropoelastin.
This protein consists of an elongated (70^80 nm) dimer with
some £exibility in its structure [32] and was already known to
be associated with micro¢brils composed primarily of ¢brillin
or ¢bronectin [16,36,37]. This has been supported by direct
binding of the proteins involved to one another [16,28] and
additional ¢bulin-2 ligands such as nidogen-1, perlecan and
endostatin were also identi¢ed in these assays [28,29]. Since
tropoelastin seems not to have a distinct a⁄nity for ¢brillin
[18], it is tempting to speculate that ¢bulin-2 could mediate
the attachment of the corresponding micro¢brils to elastin
structures. The related component ¢bulin-1 has a 30-fold low-
er a⁄nity for tropoelastin and does not bind to ¢brillin [16],
but does bind to several other extracellular ligands including
laminin-1, nidogen-1 and endostatin [27,29]. The ultrastruc-
tural localization of ¢bulin-1 on skin elastic ¢bers indicates
a primary interaction with the amorphous component rather
than micro¢brils [15], in agreement with the other observa-
tions. Our data on two rather low binding recombinant frag-
ments of ¢bulin-2 that span the entire size of the protein [32]
indicate that multiple interaction sites are required for e⁄cient
binding. They certainly include calcium binding domains II of
both ¢bulin-2 and ¢bulin-1 since calcium seems to be essential
for e⁄cient binding to tropoelastin. This has set the stage for
a more precise mapping of binding epitopes on ¢bulin-1, as
shown in other studies for the ligands nidogen-1 [38] and the
lectin binding domains of aggrecan and versican [39].
An unexpected but relatively strong ligand for tropoelastin
was nidogen-2, which is an isoform of the ubiquitous base-
ment membrane component nidogen-1. Nidogen-2 has a sim-
ilar elongated (40^50 nm) structure and was localized to base-
ment membranes and other extracellular regions [30]
including, as shown here, the elastic lamellae of aorta. Nido-
gen-2 has a distinct in vitro binding capacity for perlecan,
collagen IV and endostatin but its binding to laminin-1 is
much lower [17,30]. Nidogen-1 is known to bind strongly to
laminin-1 with Kd = 0.5 nM [26] but apparently has no distinct
a⁄nity for tropoelastin. Since the collagen XVIII-derived en-
dostatin also has no a⁄nity for tropoelastin, its localization to
the aortic media may be explained by binding to either nido-
gen-2 or ¢bulin-2 [17].
Various elastic ¢bers are also known to contain heparan
sulfate proteoglycans [3], including perlecan [17], the major
proteoglycan of basement membranes [40]. Perlecan has a
considerable potential for interactions with other extracellular
ligands, many of which bind to the C-terminal domains IV
and V or the N-terminal heparan sulfate chains [33]. Tropo-
elastin binding to perlecan, however, occurs with moderate
a⁄nity to the central domain III-2, which also carries a bind-
ing site for platelet-derived growth factor [41]. Laminin-1 is
also a typical basement membrane protein and could not be
detected on the elastic sheets of the aorta. Yet it showed a
reasonable a⁄nity for tropoelastin and we speculate that this
binding may be involved in connecting elastic ¢bers to base-
Fig. 4. Immunogold localization of tropoelastin and its potential ligands on elastic lamellae in the media of mouse aorta. Staining was with an
antiserum against tropoelastin (A) and a⁄nity-puri¢ed antibodies against ¢bulin-2 (B), ¢bulin-1C (C) and nidogen-2 (D). The major staining is
on amorphous and micro¢brillar parts of the matrix, but additional intracellular staining is also seen in (B) and (D). m, smooth muscle cell ; n,
nucleus. Bars indicate 0.25 Wm.
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ment membranes surrounding smooth muscle cells in vessel
walls. The tropoelastin binding fragments E3 and E8 of lam-
inin contain the ¢ve LG modules of the K1 chain which are
implicated in major cellular interactions and possess strong
binding epitopes for heparin and K-dystroglycan [42,43].
Whether tropoelastin modulates such activities remains an
interesting aspect to study.
Elastin-associated proteins such as ¢brillins, LTBPs, emilin
and MAGP-1 [7,8,18,19,44] have been considered to be essen-
tial for elastogenesis in tissues and to promote the polymer-
ization of tropoelastin. The ¢ve novel tropoelastin ligands
described here may also be involved in these processes. The
particular contribution of each component still needs to be
clari¢ed in order to fully understand the supramolecular or-
ganization of elastic ¢bers.
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